Anti-Mullerian Hormone levels after ovarian protection with gonadotropin-releasing hormone agonist during chemotherapy in breast cancer patients

被引：0
|
作者：
Choi, Y. M. [1 ,2 ]
Shin, J. J. [3 ]
Kim, H. [1 ]
Lee, K. H. [4 ]
Kim, T. Y. [4 ]
Han, W. [5 ]
Im, S. A. [4 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Med Res Ctr, Inst Reprod Med & Populat, Seoul, South Korea
[3] Heryoojae Womens Hosp, Fertil Ctr, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[5] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea
来源：
HUMAN REPRODUCTION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-430
引用
收藏
页码：339 / 339
页数：1
相关论文
共 50 条
  • [41] The roles of anti-Mullerian hormone in breast cancer
    Chen, Xuan
    Liu, Sixuan
    Peng, Xue
    Zong, Xiangyun
    ENDOCRINE-RELATED CANCER, 2023, 30 (10)
  • [42] OVARIAN RESPONSE TO HUMAN MENOPAUSAL GONADOTROPIN AFTER THERAPY WITH THE GONADOTROPIN-RELEASING HORMONE AGONIST LEUPROLIDE
    NADER, S
    BERKOWITZ, AS
    WINKEL, CA
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1988, 158 (02) : 403 - 404
  • [43] Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment
    Peñarrubia, J
    Fábregues, F
    Manau, D
    Creus, M
    Casals, G
    Casamitjana, R
    Carmona, F
    Vanrell, JA
    Balasch, J
    HUMAN REPRODUCTION, 2005, 20 (04) : 915 - 922
  • [44] Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients
    Kim, Hee Jeong
    Yoon, Tae-In
    Chae, Hee Dong
    Kim, Jeong Eun
    Chae, Eun Young
    Yu, Jong Han
    Sohn, Guiytm
    Ko, Beom Seok
    Lee, Jong Won
    Son, Byung Ho
    Ahn, Sei Hyun
    JOURNAL OF BREAST CANCER, 2015, 18 (04) : 365 - 370
  • [45] THE PREDICTIVE VALUE OF SERUM ANTI-MULLERIAN HORMONE LEVELS AFTER SHORT-ACTING GONADOTROPHIN-RELEASING HORMONE AGONIST TREAMENT ON CONTROLLED OVARIAN STIMULATION
    Ye, Y.
    Wu, R. R.
    Du, J.
    FERTILITY AND STERILITY, 2013, 100 (03) : S327 - S327
  • [46] PRE-CHEMOTHERAPY LEVELS OF FOLLICLE STIMULATING HORMONE AND ANTI-MULLERIAN HORMONE PREDICT TIME TO RETURN OF OVARIAN FUNCTION IN YOUNG BREAST CANCER PATIENTS.
    Haunschild, C.
    Sammel, M.
    Chung, K.
    DeMichele, A.
    Su, H. I.
    FERTILITY AND STERILITY, 2013, 100 (03) : S44 - S44
  • [47] Anti-mullerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy
    Freour, T.
    Barriere, P.
    Masson, D.
    EUROPEAN JOURNAL OF CANCER, 2017, 74 : 1 - 8
  • [48] Impact of breast cancer on anti-mullerian hormone levels in young women
    Su, H. I.
    Flatt, S. W.
    Natarajan, L.
    DeMichele, A.
    Steiner, A. Z.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (02) : 571 - 577
  • [49] Impact of breast cancer on anti-mullerian hormone levels in young women
    H. I. Su
    S. W. Flatt
    L. Natarajan
    A. DeMichele
    A. Z. Steiner
    Breast Cancer Research and Treatment, 2013, 137 : 571 - 577
  • [50] Anti-Mullerian Hormone and Ovarian Function after Hysterectomy
    Trabuco, Emanuel C.
    Moorman, Patricia G.
    Weaver, Amy L.
    William, Cliby A.
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 101A - 102A
12345